statistiche ricercatore

ARMAROLI, Annarita

Distribuzione geografica

Continente	#
NA - Nord America	1429
EU - Europa	690
AS - Asia	155
SA - Sud America	5
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2280

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1428
PL - Polonia	332
DE - Germania	103
CN - Cina	99
IT - Italia	77
UA - Ucraina	54
TR - Turchia	47
GB - Regno Unito	41
BE - Belgio	23
SE - Svezia	23
RU - Federazione Russa	18
FI - Finlandia	13
BR - Brasile	4
VN - Vietnam	4
ES - Italia	3
NL - Olanda	2
AE - Emirati Arabi Uniti	1
CA - Canada	1
CL - Cile	1
EU - Europa	1
IN - India	1
IR - Iran	1
KZ - Kazakistan	1
PH - Filippine	1
RO - Romania	1
Totale	2280

Salva come PNG Salva come JPEG

Città	#
Warsaw	332
Fairfield	246
Woodbridge	192
Chandler	147
Ann Arbor	140
Houston	88
Cambridge	82
Ashburn	80
Wilmington	78
Jacksonville	75
Seattle	73
Ferrara	40
Beijing	34
Izmir	29
Milan	22
Bremen	21
Brussels	21
Princeton	21
Falls Church	14
Nanjing	14
Shenyang	14
Boardman	13
San Diego	12
Addison	6
Des Moines	6
Hebei	6
Changsha	5
London	5
Nanchang	5
Dearborn	4
São Paulo	4
Trebaseleghe	4
Dong Ket	3
Jinan	3
Ningbo	3
Redwood City	3
Tianjin	3
Zhengzhou	3
Jiaxing	2
Kunming	2
Lanzhou	2
Monmouth Junction	2
Orange	2
Phoenix	2
Redmond	2
Rome	2
Varazze	2
Waanrode	2
Almaty	1
Alpedrete	1
Andover	1
Barcelona	1
Birmingham	1
Chicago	1
Edinburgh	1
Guarda Veneta	1
Haikou	1
Hangzhou	1
Hanoi	1
Madrid	1
Manila	1
Modena	1
Mountain View	1
New York	1
Norwalk	1
Reggio Nell'emilia	1
Sabz	1
San Mateo	1
Taizhou	1
Toronto	1
Yellow Springs	1
Totale	1894

Salva come PNG Salva come JPEG

Nome	#
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy	307
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression	290
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools	144
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy	137
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype	135
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype	132
Paternal germline mosaicism in collagen VI related myopathies	125
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: Implications for clinical trials	119
Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.	119
Cyclosporine a in Ullrich congenital muscular dystrophy: Long-term results	111
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up	102
A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation	99
Huntington's disease-like presentation in Spinocerebellar ataxia type 12	97
Genetic counseling for women referred for advanced maternal age: a telegenetic approach	95
Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia	93
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript	74
Lamin A/C Missense Mutation R216C Pinpoints Overlapping Features Between Brugada Syndrome and Laminopathies	51
Hypospadias prevalence in the Emilia Romagna Region registry: Increasing or methodology?	38
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients	26
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics	15
TRANSCRIPTIONAL PROFILING IN DUCHENNE MUSCULAR DYSTROPHY REVEALED A PROFOUND DEREGULATION OF BOTH CIRCADIAN RHYTHM GENES AND GENES INVOLVED IN MUSCLE REGENERATIVE PROCESS AS POSSIBLE NEW DISEASE BIOMARKERS	8
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy	6
TeleNEwCARe: An Italian case-control telegenetics study in patients with Hereditary NEuromuscular and CARdiac diseases	1
Totale	2324

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	5124
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	5124

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	9	0	0	0	0	0	0	0	0	0	0	0	9
2018/2019	432	12	12	12	12	19	14	36	9	33	63	99	111
2019/2020	570	76	25	29	80	42	63	55	47	44	50	36	23
2020/2021	385	33	38	22	53	23	48	21	41	9	44	33	20
2021/2022	260	19	24	5	9	8	21	31	11	12	23	29	68
2022/2023	333	26	44	11	34	65	31	29	35	32	5	21	0
Totale													2324